New antibody weapon tested against silent liver virus
NCT ID NCT05856890
Summary
This early-stage study is testing a new lab-made antibody called HepB mAb19 in people with chronic hepatitis B who are already taking standard antiviral pills. Researchers want to see if a single dose is safe, how long it stays in the body, and if it can help lower the amount of hepatitis B virus. The study will enroll 37 participants who will receive either the antibody or a placebo and be followed for nearly a year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Rockefeller University
RECRUITINGNew York, New York, 10065, United States
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.